Observational studyEuropean journal of clinical nutrition2026
Vitamin D status and response to supplementation in very preterm infants: A prospective cohort study.
Observational study in European journal of clinical nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVery preterm infants are at high risk of vitamin D deficiency (VDD), which contributes to metabolic bone disease (MBD) and other morbidities. Despite guidelines, optimal dosing remains uncertain. We determined VDD incidence and evaluated 25-hydroxyvitamin D [25(OH)D] responses to varying vitamin D intakes during the first 8 weeks of life.
methodsThis prospective cohort enrolled infants born at <32 weeks' gestation or birth weight <1500 g. Vitamin D supplementation followed institutional policy. Infants were categorized by total intake (parenteral plus enteral) during weeks 0-4: <400, 400-700, or >700 IU/kg/day. Serum 25(OH)D was measured at birth, 4, and 8 weeks. Biochemical markers and MBD screening were performed. VDD was defined as 25(OH)D < 20 ng/mL and excess (VDE) as >100 ng/mL.
resultsAmong 126 infants (gestational age 30 [27, 31] weeks; birth weight 1230 [950, 1570] g), 94.3% had VDD at birth. At 4 weeks, VDD persisted in 17.8% receiving <400 IU/kg/day and 6.5% receiving 400-700 IU/kg/day; vitamin D excess (VDE) occurred in 3.3% and 3.2%, respectively. At 8 weeks, normal 25(OH)D was achieved in 90.1% receiving <400 IU/kg/day and 77.4% receiving 400-700 IU/kg/day, while VDE increased to 8.6% and 22.6%, respectively. Biochemical markers remained normal; only one infant developed MBD.
conclusionsVDD is highly prevalent at birth in very preterm infants. Daily intake <400 IU/kg generally normalizes vitamin D status by 8 weeks while minimizing risk of excessive vitamin D. Higher doses may provide no additional benefit and increase risk of exceeding 25(OH)D levels. CLINICAL
trial registrationThai Clinical Trials Registry. Registration number TCTR20230725007. Web link: http://www.thaiclinicaltrials.org/show/TCTR20230725007 .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.